Search Results - "Caillot, D"

The Reversed Halo Sign: Pathognomonic Pattern of Pulmonary Mucormycosis in Leukemic Patients With Neutropenia? by Legouge, C., Caillot, D., Chrétien, M.-L., Lafon, I., Ferrant, E., Audia, S., Pagès, P.-B., Roques, M., Estivalet, L., Martin, L., Maitre, T., Bastie, J.-N., Dalle, F.

“…Background. Pulmonary mucormycosis (PM) is a life-threatening fungal infection with an increasing incidence among patients with acute leukemia. In some…”
Get full text

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion by Toma, A, Kosmider, O, Chevret, S, Delaunay, J, Stamatoullas, A, Rose, C, Beyne-Rauzy, O, Banos, A, Guerci-Bresler, A, Wickenhauser, S, Caillot, D, Laribi, K, De Renzis, B, Bordessoule, D, Gardin, C, Slama, B, Sanhes, L, Gruson, B, Cony-Makhoul, P, Chouffi, B, Salanoubat, C, Benramdane, R, Legros, L, Wattel, E, Tertian, G, Bouabdallah, K, Guilhot, F, Taksin, A L, Cheze, S, Maloum, K, Nimuboma, S, Soussain, C, Isnard, F, Gyan, E, Petit, R, Lejeune, J, Sardnal, V, Renneville, A, Preudhomme, C, Fontenay, M, Fenaux, P, Dreyfus, F

“…After failure of erythropoiesis-stimulating agents (ESAs), lenalidomide (LEN) yields red blood cell (RBC) transfusion independence (TI) in 20–30% of lower-risk…”
Get full text

French early nationwide idecabtagene vicleucel chimeric antigen receptor T‐cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real‐world IFM study from the DESCAR‐T registry by Ferment, B., Lambert, J., Caillot, D., Lafon, I., Karlin, L., Lazareth, A., Touzeau, C., Leleu, X., Moya, N., Harel, S., Perrot, A., Bories, P., Vincent, L., Lamure, S., Mohty, M., Malard, F., Manier, S., Yakoub‐Agha, I., Schiano De Colella, J.‐M., Brisou, G., Talbot, A., Decaux, O., Houot, R., Le Gouill, S., Bigot, N., Facon, T., Corre, J., Moreau, P., Arnulf, B.

“…Summary Idecabtagene vicleucel (ide‐cel), a chimeric antigen receptor T‐cell therapy targeting B‐cell maturation antigen (BCMA), received early access program…”
Get full text

Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis by Denning, David W., Ribaud, Patricia, Milpied, Noel, Caillot, Denis, Herbrecht, Raoul, Thiel, Eckhard, Haas, Andrea, Ruhnke, Markus, Lode, Hartmut

“…To evaluate the efficacy and safety of voriconazole in acute invasive aspergillosis (IA), an open, noncomparative multicenter study was conducted…”
Get full text

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients by Hebraud, B, Leleu, X, Lauwers-Cances, V, Roussel, M, Caillot, D, Marit, G, Karlin, L, Hulin, C, Gentil, C, Guilhot, F, Garderet, L, Lamy, T, Brechignac, S, Pegourie, B, Jaubert, J, Dib, M, Stoppa, A-M, Sebban, C, Fohrer, C, Fontan, J, Fruchart, C, Macro, M, Orsini-Piocelle, F, Lepeu, G, Sohn, C, Corre, J, Facon, T, Moreau, P, Attal, M, Avet-Loiseau, H

“…Deletions of the 1p region appear as a pejorative prognostic factor in multiple myeloma patients (especially 1p22 and 1p32 deletions) but there is a lack of…”
Get full text

Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma by Leleu, X, Fouquet, G, Hebraud, B, Roussel, M, Caillot, D, Chrétien, M L, Arnulf, B, Szalat, R, Garderet, L, Benajiba, L, Pegourie, B, Regny, C, Royer, B, Caulier, A, Stoppa, A M, Garciaz, S, Touzeau, C, Chaleteix, C, Fermand, J P, Loiseau, H A, Facon, T, Attal, M, Moreau, P

Get full text

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma by LODE, Laurence, EVEILLARD, Marion, GUILHOT, François, CAILLOT, Denis, MARIT, Gérald, MATHIOT, Claire, FACON, Thierry, ATTAL, Michel, HAROUSSEAU, Jean-Luc, MOREAU, Philippe, MINVIELLE, Stéphane, AVET-LOISEAU, Hervé, TRICHET, Valérie, SOUSSI, Thierry, WUILLEME, Soraya, RICHEBOURG, Steven, MAGRANGEAS, Florence, IFRAH, Norbert, CAMPION, Loic, TRAULLE, Catherine

“…Deletion of the 17p13 chromosomal region [del(17p)] is associated with a poor outcome in multiple myeloma. Most of the studies have targeted the TP53 gene for…”
Get full text

Emergency and elective pulmonary surgical resection in haematological patients with invasive fungal infections: a report of 50 cases in a single centre by Chretien, M.-L., Legouge, C., Pagès, P.-B., Lafon, I., Ferrant, E., Plocque, A., Favennec, C., Estivalet, L., Bottolier-Lemallaz, E., Dalle, F., Bastie, J.-N., Bernard, A., Caillot, D.

“…Invasive fungal infections (IFI) remain life-threatening complications in haematological patients. The aim of the study was to present the experience of a…”
Get full text

Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience by Avet-Loiseau, H, Roussel, M, Campion, L, Leleu, X, Marit, G, Jardel, H, Dib, M, Decaux, O, Lamy, T, Tiab, M, Cony-Makhoul, P, Banos, A, Lepeu, G, Lifermann, F, Macro, M, Kolb, B, Hulin, C, Caillot, D, Traulle, C, Mathiot, C, Royer, B

Get full text

First case of proven invasive pulmonary infection due to Trichoderma longibrachiatum in a neutropenic patient with acute leukemia by Sautour, M., Chrétien, M.L., Valot, S., Lafon, I., Basmaciyan, L., Legouge, C., Verrier, T., Gonssaud, B., Abou-Hanna, H., Dalle, F., Caillot, D.

“…Trichoderma species are saprophytic filamentous fungi that can be found all over the word. These fungi show increasing medical importance as opportunistic…”
Get full text

A retrospective series of gut aspergillosis in haematology patients by Kazan, E., Maertens, J., Herbrecht, R., Weisser, M., Gachot, B., Vekhoff, A., Caillot, D., Raffoux, E., Fagot, T., Reman, O., Isnard, F., Thiebaut, A., Bretagne, S., Cordonnier, C.

“…Gut invasive aspergillosis is an extremely rare infection in immunocompromised patients. The goal of this retrospective multicentre study is to report on cases…”
Get full text

Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With Neutropenia by CAILLOT, Denis, COUAILLIER, Jean-Francois, GUY, Henri, BERNARD, Alain, CASASNOVAS, Olivier, DENNING, David W, MANNONE, Lionel, LOPEZ, Jose, COUILLAULT, Gerard, PIARD, Francoise, VAGNER, Odile

“…In patients with neutropenia, thoracic computed tomography (CT) halo and air-crescent signs are recognized as major indicators of invasive pulmonary…”
Get full text

Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis by Caillot, D

“…The efficacy and safety of 2 weeks of intravenous itraconazole (200 mg twice daily for 2 days, then 200 mg once daily for 12 days) followed by 12 weeks of oral…”
Get more information

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma by Fouquet, G., Pegourie, B., Macro, M., Petillon, M.O., Karlin, L., Caillot, D., Roussel, M., Arnulf, B., Mathiot, C., Marit, G., Kolb, B., Stoppa, A.M., Brechiniac, S., Richez, V., Rodon, P., Banos, A., Wetterwald, M., Garderet, L., Royer, B., Hulin, C., Benbouker, L., Decaux, O., Escoffre-Barbe, M., Fermand, J.P., Attal, M., Avet-Loiseau, H., Moreau, P., Facon, T., Leleu, X.

“…The IFM2009-02 trial studied pomalidomide (4 mg daily, 21/28 versus 28/28) and dexamethasone in very advanced relapsed or refractory multiple myeloma (RRMM)…”
Get full text

Efficacy of bendamustine in relapsed/refractory myeloma patients: results from the French compassionate use program by Damaj, G., Malard, F., Hulin, C., Caillot, D., Garidi, R., Royer, B., Marit, G., Stoppa, A.M., Banos, A., Morineau, N., Moreau, P., Fitoussi, O., Tiab, M.

“…Abstract One hundred and ten patients with multiple myeloma were treated with bendamustine as part of a French compassionate use program. To receive…”
Get full text

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery by Caillot, D, Casasnovas, O, Bernard, A, Couaillier, J F, Durand, C, Cuisenier, B, Solary, E, Piard, F, Petrella, T, Bonnin, A, Couillault, G, Dumas, M, Guy, H

“…The prognosis of invasive pulmonary aspergillosis (IPA) occurring in neutropenic patients remains poor. We studied whether new strategies for early diagnosis…”
Get more information

P955: CARFILZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL‐LIFE EXPERIENCE OF EMMY by Hulin, C., Macro, M., Perrot, A., Royer, B., Caillot, D., Belhadj, K., Frenzel, L., Benramdane, R., Demarquette, H., Bareau, B., Darre, S., Calmettes, C., Le Calloch, R., Bouketouche, M., Laribi, K., Texier, N., Willaime, M., Deal, C., Moreau, P., Decaux, O.

Get full text

P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH‐RISK CYTOGENETICS. IFM 2014‐01 by Bobin, A., Manier, S., De Keizer, J., Karlin, L., Perrot, A., Hulin, C., Caillot, D., Mariette, C., Lenain, P., Richez, V., Tiab, M., Touzeau, C., Jaccard, A., Decaux, O., Araujo, C., Belhadj, K., Benboubker, L., Déal, C., Macro, M., Vincent, L., Arnulf, B., Bareau, B., Braun, T., Calmettes, C., mamoun, D., Zerazhi, H., Demarquette, H., Feugier, P., Fohrer‐sonntag, C., Godet, S., Petillon, M.‐O., Avet‐Loiseau, H., Leleu, X.

Get full text

Intravenous Itraconazole Followed by Oral Itraconazole in the Treatment of Invasive Pulmonary Aspergillosis in Patients with Hematologic Malignancies, Chronic Granulomatous Disease, or AIDS by Caillot, D., Bassaris, H., McGeer, A., Arthur, C., Prentice, H. G., Seifert, W., De Beule, K.

“…The pharmacokinetics, efficacy, and safety of intravenous (iv) itraconazole (2 days at 400 mg/day, 12 days at 200 mg/day), followed by 12 weeks of oral…”
Get full text

Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials by MOREAU, P, ATTAL, M, WETTERWALD, M, MATHIOT, C, CAILLOT, D, BERTHOU, C, BENBOUBKERL, L, GARDERET, L, CHALETEIX, C, TRAULLA, C, FUZIBET, J. G, JAUBERT, J, GARBAN, F, LAMY, T, CASASSUS, P, DIB, M, KOLB, B, DORVAUX, V, GROSBOIS, B, YAKOUB-AGHA, I, HAROUSSEAU, J. L, AVET-LOISEAU, H, HULIN, C, FACON, T, MARIT, G, MICHALLET, M, DOYEN, C, LEYVRAZ, S, MOHTY, M

“…One hundred de novo multiple myeloma patients with t(4;14) treated with double intensive therapy according to IFM99 protocols were retrospectively analyzed…”
Get full text